Saleh Rashed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Saleh Rashed has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Anupama Reddy
Vindhya Data Science, Morrisville, NC
40 shared publications - Christy Wang
Eloxx Pharmaceuticals, Watertown, New York
40 shared publications - David Sidransky
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
40 shared publications - Esteban Terzo
Eloxx Pharmaceuticals, Watertown, New York
40 shared publications - Michael Caponegro
Vindhya Data Science, Data Science, Morrisville, North Carolina
40 shared publications - Roger B. Clark
Eloxx Pharmaceuticals, Watertown, New York
40 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in enzalutamide treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in enzalutamide treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Identification of paired centromeres from sister chromatids
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Identification of paired centromeres from sister chromatids
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Seven Supplementary Figures and Legends
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Seven Supplementary Figures and Legends
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in abiraterone treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in abiraterone treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in vehicle treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in vehicle treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Video montage comparing mitosis of vehicle control with abiraterone treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Video montage comparing mitosis of vehicle control with abiraterone treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Cellular division that occurred in a manner that was not parallel to the growth surface
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Cellular division that occurred in a manner that was not parallel to the growth surface
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Example of mitotic arrest and cell death caused by abiraterone and onvansertib
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Example of mitotic arrest and cell death caused by abiraterone and onvansertib